Recurrent CDK7 deletion was also identified in triple-negative breast cancer (TNBC).339 On the other side, several studies have shown elevated CDK7 expression in tumor tissues compared to normal counterparts across various neoplasms, including but not limited to breast cancer, correlating with poor prognosis. This evidence concerns the gene CDK7 and triple-negative breast carcinoma.